Innate Cancer immunology

Cancer immunology is a dynamic and rapidly advancing branch of immunology that explores the complex interactions between the immune system and cancer cells (also referred to as tumors or malignancies). This field is at the forefront of biomedical research, with the primary goal of developing innovative immunotherapeutic strategies to prevent, treat, and slow the progression of cancer.

A central focus in cancer immunology is the immune system’s ability to recognize and respond to cancer-specific antigens. This understanding has fuelled the development of targeted therapies, including cancer vaccines, monoclonal antibodies, immune checkpoint inhibitors, and T-cell-based treatments, many of which have already transformed cancer care and continue to evolve through next-generation technologies.

In addition to therapeutic advances, the identification of tumor-associated antigens and immune biomarkers is leading to more precise diagnostic tools and personalized treatment approaches. A key discovery in this area was published by Ohtani in 2007, demonstrating the prognostic value of tumor-infiltrating lymphocytes (TILs) in human colorectal cancer. The presence of lymphocytic infiltration, particularly those triggering inflammatory responses, was associated with improved patient survival, suggesting that an endogenous anti-tumor immune response plays a meaningful role in disease outcomes.

By 2025, cancer immunology continues to push boundaries leveraging advancements in genomics, artificial intelligence, and cellular engineering to refine immunotherapies, overcome tumor immune evasion, and ultimately improve survival rates across a wide range of malignancies. The integration of cancer immunology into precision medicine frameworks marks a transformative era in oncology, offering renewed hope for effective, long-term cancer control.

 

    Related Conference of Innate Cancer immunology

    July 23-24, 2025

    30th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France
    September 22-23, 2025

    21st Global Biomarkers and Clinical Research Summit

    Paris, France
    September 25-26, 2025

    3rd International Conference on Oral Health and Dentistry

    Zurich, Switzerland
    October 27-28, 2025

    10th Global Summit on Midwifery and Womens Health

    Madrid, Spain
    October 30-31, 2025

    6th International Conferences in COPD & Lung Disease

    Paris, France
    November 13-14, 2025

    5th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 13-14, 2025

    11th World Holistic Nursing Conference

    Bali, Indonesia
    November 20-21, 2025

    6th Global Summit on Public Health

    Amsterdam, Netherlands
    November 24-25, 2025

    4th Global Conference on Aging and Gerontology

    Barcelona, Spain
    November 24-25, 2025

    11th Global Public Health, Occupational Safety and Health Policy

    Aix-en-Provence, France
    December 04-05, 2025

    Innateimmunity

    Dubai, UAE
    December 17-18, 2025

    8th Annual Congress on Wellness and Alternative Healthcare Informatics

    Aix-en-Provence, France
    December 17-18, 2025

    12th World congress on Hospice and Palliative care

    Aix-en-Provence, France
    December 29-30, 2025

    13th International Conference on Hospital Management and Health Care

    Amsterdam, Netherlands
    January 28-29, 2026

    43rd International Conference on Women's Health

    Bangkok, Thailand
    March 12-13, 2026

    8th International Conference on Digital Health

    London, UK
    April 20-21, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    April 27-28, 2026

    8th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada

    Innate Cancer immunology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in